comparemela.com

Latest Breaking News On - Connect biopharma holdings limited - Page 3 : comparemela.com

Connect Biopharma (CNTB) Reports Positive Rademikibart Global Phase 2b Topline Results

Connect Biopharma (CNTB) Reports Positive Rademikibart Global Phase 2b Topline Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Connect Biopharma (CNTB) to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12

Connect Biopharma (CNTB) to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Positive Long-Term Data Shown in Patients with Atopic Dermatitis Treated with Rademikibart

These pivotal trial results from a study in China indicated the potential of this drug as a quarterly treatment for individuals with eczema.

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Why Is Skin Disease-Focused Connect Biopharma Stock Lower Today?

Connect Biopharma Holdings Limited CNTB released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's…

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.